Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Inflammatory breast carcinoma and locally advanced breast carcinoma: characterisation with MR imaging.

Girardi V, Carbognin G, Camera L, Bonetti F, Manfrin E, Pollini G, Pozzi Mucelli R.

Radiol Med. 2011 Feb;116(1):71-83. doi: 10.1007/s11547-010-0590-4. Epub 2010 Oct 6. English, Italian.

PMID:
20927653
2.

Inflammatory breast carcinoma in magnetic resonance imaging: a comparison with locally advanced breast cancer.

Renz DM, Baltzer PA, Böttcher J, Thaher F, Gajda M, Camara O, Runnebaum IB, Kaiser WA.

Acad Radiol. 2008 Feb;15(2):209-21. doi: 10.1016/j.acra.2007.09.011.

PMID:
18206620
3.

Inflammatory breast cancer: MR imaging findings.

Carbognin G, Calciolari C, Girardi V, Camera L, Pollini G, Pozzi Mucelli R.

Radiol Med. 2010 Feb;115(1):70-82. doi: 10.1007/s11547-009-0475-6. Epub 2009 Dec 16. English, Italian.

PMID:
20017008
4.
5.
6.

Inflammatory breast cancer in the Netherlands; improved survival over the last decades.

van Uden DJ, Bretveld R, Siesling S, de Wilt JH, Blanken-Peeters CF.

Breast Cancer Res Treat. 2017 Apr;162(2):365-374. doi: 10.1007/s10549-017-4119-6. Epub 2017 Jan 30.

PMID:
28138891
7.

Inflammatory breast cancer: is it really a separate entity?

Bastawisy A, Gaafar R, Eisa S, Amira G, Helal M.

Ecancermedicalscience. 2012;6:250. doi: 10.3332/ecancer.2012.250. Epub 2012 Apr 12.

8.

Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease.

Cristofanilli M, Valero V, Buzdar AU, Kau SW, Broglio KR, Gonzalez-Angulo AM, Sneige N, Islam R, Ueno NT, Buchholz TA, Singletary SE, Hortobagyi GN.

Cancer. 2007 Oct 1;110(7):1436-44.

9.

What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?

Il'yasova D, Siamakpour-Reihani S, Akushevich I, Akushevich L, Spector N, Schildkraut J.

Breast Cancer Res Treat. 2011 Nov;130(2):691-7. doi: 10.1007/s10549-011-1719-4. Epub 2011 Aug 18.

10.

Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.

Levine PH, Portera CC, Hoffman HJ, Yang SX, Takikita M, Duong QN, Hewitt SM, Swain SM.

Clin Breast Cancer. 2012 Aug;12(4):232-9. doi: 10.1016/j.clbc.2012.04.005. Epub 2012 Jun 12.

PMID:
22694825
11.

Prognostic value of body mass index in locally advanced breast cancer.

Dawood S, Broglio K, Gonzalez-Angulo AM, Kau SW, Islam R, Hortobagyi GN, Cristofanilli M.

Clin Cancer Res. 2008 Mar 15;14(6):1718-25. doi: 10.1158/1078-0432.CCR-07-1479.

12.

Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.

Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, Cristofanilli M.

Cancer. 2011 May 1;117(9):1819-26. doi: 10.1002/cncr.25682. Epub 2010 Nov 29.

13.

Risk factors for inflammatory breast cancer and other invasive breast cancers.

Schairer C, Li Y, Frawley P, Graubard BI, Wellman RD, Buist DS, Kerlikowske K, Onega TL, Anderson WF, Miglioretti DL.

J Natl Cancer Inst. 2013 Sep 18;105(18):1373-84. doi: 10.1093/jnci/djt206.

14.

Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.

Chaher N, Arias-Pulido H, Terki N, Qualls C, Bouzid K, Verschraegen C, Wallace AM, Royce M.

Breast Cancer Res Treat. 2012 Jan;131(2):437-44. doi: 10.1007/s10549-011-1422-5. Epub 2011 Mar 1.

15.

MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?

Hahn SY, Han BK, Ko EY, Shin JH, Hwang JY, Nam M.

Acta Radiol. 2013 Sep;54(7):742-8. doi: 10.1177/0284185113484640. Epub 2013 Apr 30.

PMID:
23588154
16.

[Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].

Benbrahim Z, Berrada A, Amaadour L, Zahra El M'rabet F, Elfatemi H, Elfakir S, Mellas N, Arifi S.

Gynecol Obstet Fertil Senol. 2017 Nov;45(11):604-608. doi: 10.1016/j.gofs.2017.09.005. French.

PMID:
29100820
17.

Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study.

Renz DM, Baltzer PA, Böttcher J, Thaher F, Gajda M, Camara O, Runnebaum IB, Kaiser WA.

Eur Radiol. 2008 Nov;18(11):2370-80. doi: 10.1007/s00330-008-1029-3. Epub 2008 Jun 4.

PMID:
18523781
18.

Interleukin-18 (IL-18) is equally expressed in inflammatory breast cancer and noninflammatory locally advanced breast cancer: A possible association with chemotherapy response.

Aguiar MAN, Wanderley CWS, Nobre LMS, Alencar MRM, Saldanha MDPS, Souza AM, Wong DVT, Barros PG, Almeida PRC, Lima-Júnior RCP, Ribeiro RA.

Asia Pac J Clin Oncol. 2018 Apr;14(2):e138-e144. doi: 10.1111/ajco.12722. Epub 2017 Aug 2.

PMID:
28766916
19.

DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study.

Craciunescu OI, Blackwell KL, Jones EL, Macfall JR, Yu D, Vujaskovic Z, Wong TZ, Liotcheva V, Rosen EL, Prosnitz LR, Samulski TV, Dewhirst MW.

Int J Hyperthermia. 2009;25(6):405-15. doi: 10.1080/02656730903022700.

20.

Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.

Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.

Supplemental Content

Support Center